Interaction of ZnO Nanoparticles with Microbes—A Physio and Biochemical Assay

$113.00 plus tax (Refund Policy)

Buy Article:

Abstract:

The antibacterial activity of ZnO nanoparticles (nano ZnO) on various microorganisms has been investigated in this study and acting mechanism is proposed for E. coli a model organism by analyzing the growth, permeability and morphology of the bacterial cells. The experimental results indicated 1 mmoL (81.4 μg) nano ZnO could completely inhibit the growth of 107 cfu/mL bacterial cells in liquid Luria-Betrani medium. In the biochemical study, it has been observed that, nano ZnO resulted in the leakage of proteins. Chemiluminescence assay proved the generation of the reactive oxygen species into active state. When the cells of E. coli were exposed to nano ZnO, many pits were observed in bacterial cells by TEM and Fluorescence microscopy and the cells were found to be fragmentary. Released zinc ion from has been monitored by AAS. It suggested that nano ZnO is able to destroy the permeability of the bacterial membranes. Our study demonstrated that nano ZnO damages the structure of bacterial cell membrane and depressed the activity of some membranous enzymes by ROS production which caused E. coli bacteria to die eventually.

Keywords: ANTIBACTERIAL; BIOCHEMICAL STUDY; FLUORESCENCE PROBES; MECHANISM; ZNO NANOPARTICLES

Document Type: Research Article

DOI: http://dx.doi.org/10.1166/jbn.2011.1343

Publication date: December 1, 2011

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • ingentaconnect is not responsible for the content or availability of external websites
Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more